Acquisition by Vicky Hahne of 11328 shares of Celcuity LLC at 13.13 subject to Rule 16b-3

CELC Stock  USD 10.93  0.32  2.84%   
About 69% of Celcuity LLC's investor base is looking to short. The analysis of the overall investor sentiment regarding Celcuity LLC suggests that many traders are alarmed. The current market sentiment, together with Celcuity LLC's historical and current headlines, can help investors time the market. In addition, many technical investors use Celcuity LLC stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Celcuity LLC Officer: Chief Financial Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at benzinga.com
benzinga news
  
Acquisition of 11328 stock option (right to buy) at 13.13 of Celcuity LLC by Vicky Hahne on 2nd of January 2025. This event was filed by Celcuity LLC with SEC on 2025-01-02. Statement of changes in beneficial ownership - SEC Form 4

Celcuity LLC Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Celcuity LLC can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Celcuity LLC Fundamental Analysis

We analyze Celcuity LLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Celcuity LLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Celcuity LLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Liabilities

Current Liabilities Comparative Analysis

Celcuity LLC is currently under evaluation in current liabilities category among its peers. Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.

Celcuity LLC Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Celcuity LLC stock to make a market-neutral strategy. Peer analysis of Celcuity LLC could also be used in its relative valuation, which is a method of valuing Celcuity LLC by comparing valuation metrics with similar companies.

Peers

Celcuity LLC Related Equities

AVTEAerovate Therapeutics   6.17   
0%
100.0%
ANABAnaptysBio   5.46   
0%
88.0%
ACRVAcrivon Therapeutics,   4.14   
0%
67.0%
RZLTRezolute   2.31   
0%
37.0%
CCCCC4 Therapeutics   2.07   
0%
33.0%
ANTXAN2 Therapeutics   1.60   
0%
25.0%
MOLNMolecular Partners   0.00   
0%
0%
ADAGAdagene   0.54   
8.0%
0%
IKNAIkena Oncology   0.66   
10.0%
0%
HOWLWerewolf Therapeutics   0.75   
12.0%
0%
CSBRChampions Oncology   1.71   
27.0%
0%
EWTXEdgewise Therapeutics   1.72   
27.0%
0%
ANEBAnebulo Pharmaceuticals   1.85   
29.0%
0%
MNOVMediciNova   2.14   
34.0%
0%
MLYSMineralys Therapeutics,   2.74   
44.0%
0%

Complementary Tools for Celcuity Stock analysis

When running Celcuity LLC's price analysis, check to measure Celcuity LLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celcuity LLC is operating at the current time. Most of Celcuity LLC's value examination focuses on studying past and present price action to predict the probability of Celcuity LLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celcuity LLC's price. Additionally, you may evaluate how the addition of Celcuity LLC to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account